These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 1355736

  • 1. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
    Ichihara K, Nabeshima T, Kameyama T.
    Eur J Pharmacol; 1992 Mar 24; 213(2):243-9. PubMed ID: 1355736
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of D1 and D2 dopamine receptors produces additive anorectic effects.
    Ladurelle N, Duterte-Boucher D, Costentin J.
    Fundam Clin Pharmacol; 1991 Mar 24; 5(6):481-90. PubMed ID: 1683341
    [Abstract] [Full Text] [Related]

  • 3. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul 24; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 4. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun 24; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 5. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.
    Starr BS, Starr MS.
    Pharmacol Biochem Behav; 1986 Apr 24; 24(4):837-9. PubMed ID: 2940604
    [Abstract] [Full Text] [Related]

  • 6. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 24; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 7. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
    Simon P, Charpentier S, Costentin J.
    Methods Find Exp Clin Pharmacol; 1991 Mar 24; 13(2):99-104. PubMed ID: 1830125
    [Abstract] [Full Text] [Related]

  • 8. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 9. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K, Nabeshima T, Kameyama T.
    Eur J Pharmacol; 1993 Apr 06; 234(2-3):155-63. PubMed ID: 8097720
    [Abstract] [Full Text] [Related]

  • 10. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE, Holtzman SG.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):65-75. PubMed ID: 7813580
    [Abstract] [Full Text] [Related]

  • 11. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 01; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 12. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT, Wagner RL.
    J Neurochem; 1994 Jul 01; 63(1):169-76. PubMed ID: 7911508
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors.
    Starr BS, Starr MS.
    Neuropharmacology; 1986 May 01; 25(5):455-63. PubMed ID: 3488514
    [Abstract] [Full Text] [Related]

  • 18. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I, Bryer JB, Starkstein SE, Honig M, Moran TH, Robinson RG.
    Brain Res; 1990 Nov 19; 533(2):286-91. PubMed ID: 1981170
    [Abstract] [Full Text] [Related]

  • 19. Dynorphin A(1-13) preferentially inhibits behaviors induced by the D2 dopamine agonist RU 24213 but not by the D1 dopamine agonist SK&F 38393.
    Ukai M, Toyoshi T, Kameyama T.
    Pharmacol Biochem Behav; 1992 Aug 19; 42(4):755-9. PubMed ID: 1355296
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB, Criswell HE, Jensen KF, Simson PE, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1992 Aug 19; 262(2):855-65. PubMed ID: 1354257
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.